# An Investigational Drug Study in Adults With Type 2 Diabetes on Basal Insulin (MK-0941-006)

> **NCT00511472** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 70 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** MK-0941
- **DRUG:** Placebo
- **DRUG:** LANTUS insulin

## Key facts

- **NCT ID:** NCT00511472
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2015-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00511472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00511472, "An Investigational Drug Study in Adults With Type 2 Diabetes on Basal Insulin (MK-0941-006)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00511472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*